Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.05
+0.39 (1.89%)
At close: Oct 26, 2026, 4:00 PM EDT
22.00
+0.95 (4.51%)
After-hours: Oct 26, 2026, 7:55 PM EDT
Innoviva Market Cap
Innoviva has a market cap or net worth of $1.52 billion as of October 26, 2026. It is the 7,871st most valuable company in the world and the 1,965th biggest in the United States. Its market cap has increased by 36.26% in one year.
Market Cap
1.52B
Enterprise Value
1.27B
1-Year Change
36.26%
Global Rank
Country Rank
#1,965 United States
Category
ChartMarket Cap Chart
Since October 5, 2004, Innoviva's market cap has increased from $922.60M to $1.52B, an increase of 64.83%. That is a compound annual growth rate of 2.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.52B | 1.75% |
| Dec 31, 2025 | 1.49B | 37.61% |
| Dec 31, 2024 | 1.09B | 5.65% |
| Dec 29, 2023 | 1.03B | 11.18% |
| Dec 30, 2022 | 924.60M | -22.87% |
| Dec 31, 2021 | 1.20B | -4.58% |
| Dec 31, 2020 | 1.26B | -12.40% |
| Dec 31, 2019 | 1.43B | -18.66% |
| Dec 31, 2018 | 1.76B | 15.03% |
| Dec 29, 2017 | 1.53B | 31.74% |
| Dec 30, 2016 | 1.16B | -6.00% |
| Dec 31, 2015 | 1.24B | -24.18% |
| Dec 31, 2014 | 1.63B | -58.58% |
| Dec 31, 2013 | 3.94B | 81.11% |
| Dec 31, 2012 | 2.18B | 15.68% |
| Dec 30, 2011 | 1.88B | 16.19% |
| Dec 31, 2010 | 1.62B | 94.90% |
| Dec 31, 2009 | 830.80M | 8.42% |
| Dec 31, 2008 | 766.30M | -35.48% |
| Dec 31, 2007 | 1.19B | -35.96% |
| Dec 29, 2006 | 1.85B | 30.35% |
| Dec 30, 2005 | 1.42B | 49.85% |
| Dec 31, 2004 | 949.50M | 2.92% |
| Oct 5, 2004 | 922.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.58B |
| First Tracks Biotherapeutics | 1.57B |
| Intellia Therapeutics | 1.57B |
| uniQure | 1.56B |
| Ultragenyx Pharmaceutical | 1.54B |
| Structure Therapeutics | 1.51B |
| Nanobiotix | 1.47B |
| AnaptysBio | 1.46B |